---
reference_id: "PMID:1532114"
title: Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons.
authors:
- McMahon BJ
- Helminiak C
- Wainwright RB
- Bulkow L
- Trimble BA
- Wainwright K
journal: Am J Med
year: '1992'
doi: 10.1016/0002-9343(92)90073-k
content_type: abstract_only
---

# Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons.
**Authors:** McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K
**Journal:** Am J Med (1992)
**DOI:** [10.1016/0002-9343(92)90073-k](https://doi.org/10.1016/0002-9343(92)90073-k)

## Content

1. Am J Med. 1992 Mar;92(3):254-6. doi: 10.1016/0002-9343(92)90073-k.

Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons.

McMahon BJ(1), Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K.

Author information:
(1)Department of Medicine, Alaska Native Medical Center, Anchorage 99510-7741.

Comment in
    Am J Med. 1995 Jun;98(6):595-6. doi: 10.1016/s0002-9343(99)80021-7.

PURPOSE: To determine the incidence of adverse reactions to hepatitis B 
plasma-derived vaccine.
PATIENTS: Alaska natives (43,618) who received 101,360 doses of hepatitis B 
vaccine.
METHODS: All adverse reactions, excluding transient fever, myalgia, or soreness 
lasting less than 3 days, were reported. An intradermal skin test was developed 
to test purported adverse reactions. Records of the entire population were 
reviewed for Guillain-Barr√© syndrome (GBS).
SETTING: A statewide hepatitis B control program for Alaska natives.
RESULTS: Possible adverse reactions occurred in 39 persons. The most frequent 
adverse reactions were myalgia/arthralgia lasting longer than 3 days (14), 
followed by skin rashes (eight) and dizziness (seven). Skin tests were performed 
on 13 persons and were positive in five. Six of the persons with negative skin 
tests and eight persons who did not undergo skin testing received additional 
doses of vaccine without any adverse reactions. No increased incidence of GBS 
was found in the vaccinees.
CONCLUSION: Hepatitis B vaccine is safe and most adverse reactions are 
coincidental.

DOI: 10.1016/0002-9343(92)90073-k
PMID: 1532114 [Indexed for MEDLINE]